Phase IIb Trial Evaluations Of The Effectiveness Of Treatment Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475 (Pembrolizumab)
Phase of Trial: Phase I/II
Latest Information Update: 26 Feb 2016
At a glance
- Drugs Pembrolizumab (Primary) ; Dactolisib; Ipatasertib; Pictrelisib
- Indications Glioblastoma; Gliosarcoma
- Focus Therapeutic Use
- 23 Feb 2016 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.
- 27 Nov 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Nov 2015, according to ClinicalTrials.gov record.
- 27 Nov 2015 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.